Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoaki Hashimoto

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Abnormalities in electrocardiogram of patients with rheumatoid arthritis]Naoaki Hashimoto, Hajime Sano
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 30, 2004
[Epidemic hepatitis A in Japan: background and actions to be taken]Naoaki Hashimoto, Masae Ono
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 23, 2005
[Immunologic tests: Anti-calmodulin antibody]Yusei Ikeda, Naoaki Hashimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 15, 2010
[Anti-calmodulin antibody]Naoaki Hashimoto, Yusei Ikeda, Gotaro Toda
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 23, 2005
[Immunologic tests: Anti-sulfatide antibody]Naoaki Hashimoto, Yusei Ikeda, Gotaro Toda
Inorganic Chemistry|March 11, 2008
Metal effects on electronic structures of directly linked tribenzotetraazachlorin-fullerene conjugatesTakamitsu Fukuda, Satoshi Masuda, Naoaki Hashimoto, et al.
Chemical Communications (Cambridge, England)|October 7, 2014
Reduction-triggered aromatic to aromatic electronic structure switching in tribenzotetraazachlorin-fullerene conjugatesTakamitsu Fukuda, Jun Sato, Naoaki Hashimoto, et al.
Internal Medicine (Tokyo, Japan)|August 20, 2010
Black thyroidNaoto Azuma, Naoaki Hashimoto, Aki Nishioka, et al.
Clinical Pharmacology and Therapeutics|December 14, 2023
Implications of Incorporating Plasma Lipoprotein Binding into a Physiologically-Based Pharmacokinetic Model: A Simulation Study with AmiodaroneKosuke Doki, Naoaki Hashimoto, Keigo Yoshida, et al.
Internal Medicine (Tokyo, Japan)|June 20, 2017
Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid ArthritisNaoto Azuma, Kiyoshi Matsui, Naoaki Hashimoto, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Abnormalities in electrocardiogram of patients with rheumatoid arthritis]Naoaki Hashimoto, Hajime Sano
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 30, 2004
[Epidemic hepatitis A in Japan: background and actions to be taken]Naoaki Hashimoto, Masae Ono
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 23, 2005
[Immunologic tests: Anti-calmodulin antibody]Yusei Ikeda, Naoaki Hashimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 15, 2010
[Anti-calmodulin antibody]Naoaki Hashimoto, Yusei Ikeda, Gotaro Toda
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 23, 2005
[Immunologic tests: Anti-sulfatide antibody]Naoaki Hashimoto, Yusei Ikeda, Gotaro Toda
Inorganic Chemistry|March 11, 2008
Metal effects on electronic structures of directly linked tribenzotetraazachlorin-fullerene conjugatesTakamitsu Fukuda, Satoshi Masuda, Naoaki Hashimoto, et al.
Chemical Communications (Cambridge, England)|October 7, 2014
Reduction-triggered aromatic to aromatic electronic structure switching in tribenzotetraazachlorin-fullerene conjugatesTakamitsu Fukuda, Jun Sato, Naoaki Hashimoto, et al.
Internal Medicine (Tokyo, Japan)|August 20, 2010
Black thyroidNaoto Azuma, Naoaki Hashimoto, Aki Nishioka, et al.
Clinical Pharmacology and Therapeutics|December 14, 2023
Implications of Incorporating Plasma Lipoprotein Binding into a Physiologically-Based Pharmacokinetic Model: A Simulation Study with AmiodaroneKosuke Doki, Naoaki Hashimoto, Keigo Yoshida, et al.
Internal Medicine (Tokyo, Japan)|June 20, 2017
Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid ArthritisNaoto Azuma, Kiyoshi Matsui, Naoaki Hashimoto, et al.
Pageof 8